iiinova — where your digital self keeps evolving

Elvin Maharramov

@m-elvin.bsky.social

Curious Homo sapiens on a quest for microbial secrets – a PhD candidate in the Csaba Pal Lab (@csabapallab.bsky.social) decoding the evolutionary arm race between bacteria and antibiotics

Posts Replies Media

Reposted by Elvin Maharramov

Csaba Pal Laboratory @csabapallab.bsky.social · 10/04/2026

🎓 Warm congrats to Elvin Maharramov @m-elvin.bsky.social on a successful PhD defense on the principles of designing #antibiotics with limited #resistance. A timely and elegant contribution to the field of #DrugDevelopment on how to design less resistance-prone antibiotics. More info below👇

241

Elvin Maharramov @m-elvin.bsky.social · 10/02/2026

Great work from the Juhasz and Manczinger @matemanc.bsky.social labs! This study reveals five protein-level mutation “fingerprints” that influence tumor immune visibility, beyond mutation burden alone. #Cancer #Immunotherapy @molsystbiol.org

011

Reposted by Elvin Maharramov

Science X / Phys.org @sciencex.bsky.social · 03/03/2025

A dual-target antibiotic strategy, combining membrane disruption with another cellular pathway, shows promise in reducing bacterial resistance, offering a new direction in combating antimicrobial resistance. doi.org/g855sh

phys.org

Study uncovers the core principles of low-resistance antibiotics

A study published in Nature Communications has revealed novel insights into bacterial resistance and offers a promising strategy for developing antibiotics that minimize the evolution of resistance.

064

Elvin Maharramov @m-elvin.bsky.social · 25/02/2025

My first-author PhD paper is out in @naturecomms.bsky.social: A “double trouble” approach—combining membrane disruption with a key cellular pathway—dramatically limits bacterial #resistance. Discover “Exploring the principles behind antibiotics with limited resistance” #AMR #DrugDevelopment #MEvoSky

2147